Insight funds (NASDAQ: HNGE) convert 1.47M Class B into Class A, then sell

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Hinge Health, Inc. disclosed that investment entities affiliated with Insight, reported as ten percent owners, completed a large convert-and-sell transaction in the company’s Class A Common Stock. They converted 1,466,667 Class B shares into Class A and then sold the same number in multiple open-market trades at prices between roughly $81.31 and $84.59 per share, resulting in a net sale of 1,466,667 shares and no remaining derivative position from this block.

Insights

Insight-affiliated funds converted and sold 1.47M HNGE shares in a net-sell transaction.

Affiliated Insight funds, disclosed as ten percent owners of Hinge Health, Inc., converted 1,466,667 Class B Common Stock shares into Class A Common Stock and sold the entire amount in open-market trades. Sale prices ranged from about $81.305 to $84.59 per share.

This pattern is a classic exercise-or-conversion-and-sell event: the derivative Class B position was converted and fully exited, with no remaining derivative holdings shown. The filing does not quantify the funds’ overall ownership stake after these trades, so the scale is visible only for this specific block.

The transactions are economically meaningful in absolute terms, but their impact on the company’s overall float or Insight’s total ownership cannot be gauged from this information alone. Future company disclosures or ownership filings would provide additional context on remaining holdings and any broader change in control or influence.

Insider Trade Summary 10b5-1

Net Seller: 1,466,667 shares ($121,489,333)

Net Sell 28 txns

Insider Insight Holdings Group, LLC, Insight Venture Associates X, L.P., Insight Venture Associates X, Ltd., Insight Venture Partners X, L.P., Insight Venture Partners (Cayman) X, L.P., Insight Venture Partners (Delaware) X, L.P., Insight Venture Partners X (Co-Investors), L.P.

Sold 1,466,667 shs ($121.49M)

Type	Security	Shares	Price	Value
Conversion	Class A Common Stock	732,444	$0.00	--
Conversion	Class A Common Stock	17,427	$0.00	--
Conversion	Class A Common Stock	600,613	$0.00	--
Conversion	Class A Common Stock	116,183	$0.00	--
Sale	Class A Common Stock	216,787	$81.305	$17.63M
Sale	Class A Common Stock	5,158	$81.305	$419K
Sale	Class A Common Stock	177,768	$81.305	$14.45M
Sale	Class A Common Stock	34,387	$81.305	$2.80M
Sale	Class A Common Stock	72,672	$82.0479	$5.96M
Sale	Class A Common Stock	1,729	$82.0479	$142K
Sale	Class A Common Stock	59,592	$82.0479	$4.89M
Sale	Class A Common Stock	11,528	$82.0479	$946K
Sale	Class A Common Stock	162,965	$83.1765	$13.55M
Sale	Class A Common Stock	3,877	$83.1765	$322K
Sale	Class A Common Stock	133,633	$83.1765	$11.12M
Sale	Class A Common Stock	25,850	$83.1765	$2.15M
Sale	Class A Common Stock	279,671	$84.0207	$23.50M
Sale	Class A Common Stock	6,654	$84.0207	$559K
Sale	Class A Common Stock	229,334	$84.0207	$19.27M
Sale	Class A Common Stock	44,363	$84.0207	$3.73M
Sale	Class A Common Stock	349	$84.59	$30K
Sale	Class A Common Stock	9	$84.59	$761.31
Sale	Class A Common Stock	286	$84.59	$24K
Sale	Class A Common Stock	55	$84.59	$5K
Conversion	Class B Common Stock	732,444	$0.00	--
Conversion	Class B Common Stock	17,427	$0.00	--
Conversion	Class B Common Stock	600,613	$0.00	--
Conversion	Class B Common Stock	116,183	$0.00	--

Holdings After Transaction: Class A Common Stock — 732,444 shares (Indirect, See footnotes); Class B Common Stock — 3,217,008 shares (Indirect, See footnotes)

Footnotes (1)

See Exhibit 99.1 See Exhibit 99.1 See Exhibit 99.1 See Exhibit 99.1 See Exhibit 99.1 See Exhibit 99.1 See Exhibit 99.1 See Exhibit 99.1 See Exhibit 99.1 See Exhibit 99.1 See Exhibit 99.1 See Exhibit 99.1 See Exhibit 99.1 See Exhibit 99.1

Key Figures

Shares sold: 1,466,667 shares Shares converted: 1,466,667 shares Highest sale price: $84.59 per share +4 more

7 metrics

Shares sold 1,466,667 shares Total Class A shares sold in open-market trades

Shares converted 1,466,667 shares Class B Common Stock converted into Class A

Highest sale price $84.59 per share Open-market sale price for Class A on transaction date

Lowest sale price $81.305 per share Lowest reported open-market sale price in the series

Sell transactions 20 transactions Number of non-derivative open-market sale entries

Conversion transactions 8 transactions Total derivative and non-derivative conversion entries

Net share direction 1,466,667 net shares sold NetBuySellShares value from transaction summary

Key Terms

open-market sale, Class B Common Stock, derivative conversion, ten percent owner, +1 more

5 terms

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Class B Common Stock financial

"security_title": "Class B Common Stock""

A class B common stock is one of multiple types of a company’s ordinary shares that carries specific rights—often different voting power or dividend priority—compared with other classes. For investors it matters because those differences affect how much influence you have over company decisions, the income you might receive, and how freely the shares trade; think of it like owning a car with different keys: some keys let you start the engine and open the trunk, others only unlock the door.

derivative conversion financial

"transaction_action": "derivative conversion""

ten percent owner regulatory

"is_ten_percent_owner": 1"

indirect ownership regulatory

"ownership_type": "indirect""

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/29/2026 - 09:27 PM Accepted by SEC EDGAR 06/29/2026 - 09:27 PM

FAQ

What did Insight-affiliated funds do in this Hinge Health (HNGE) Form 4 filing?

Affiliated Insight funds converted and sold shares of Hinge Health. They converted 1,466,667 Class B Common Stock shares into Class A, then sold the same number in open-market trades, fully exiting this specific Class B-derived block.

How many Hinge Health (HNGE) shares were sold by the Insight entities and at what prices?

Insight-affiliated entities sold 1,466,667 Hinge Health Class A shares. The open-market sale prices ranged from about $81.305 to $84.59 per share, executed across multiple transactions on the same reported trade date.

What type of securities did the Insight entities convert in Hinge Health (HNGE)?

They converted Hinge Health Class B Common Stock into Class A Common Stock. In total, 1,466,667 Class B shares were converted, with corresponding non-derivative entries showing receipt of the same number of Class A shares before the subsequent open-market sales.

Are the Insight entities considered insiders or major shareholders of Hinge Health (HNGE)?

Yes. The filing identifies multiple Insight investment entities as ten percent owners of Hinge Health. This status requires them to report transactions on Form 4, including the conversions and open-market sales disclosed in this filing.

Did the Insight entities retain any derivative position after these Hinge Health (HNGE) transactions?

The filing’s derivative summary is empty after the reported conversions. This indicates the Class B Common Stock derivative positions tied to the 1,466,667 converted shares no longer remain outstanding following the transactions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Insight Holdings Group, LLC

(Last)

(First)

(Middle)

C/O INSIGHT PARTNERS

1114 AVENUE OF THE AMERICAS, 36TH FLOOR

(Street)

NEW YORK

10036

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Hinge Health, Inc. [ HNGE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/25/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock	06/29/2026		C		732,444	A	⁽⁸⁾	732,444	I	See footnotes⁽¹⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/29/2026		C		17,427	A	⁽⁸⁾	17,427	I	See footnotes⁽²⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/29/2026		C		600,613	A	⁽⁸⁾	600,613	I	See footnotes⁽³⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/29/2026		C		116,183	A	⁽⁸⁾	116,183	I	See footnotes⁽⁴⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/29/2026		S⁽¹⁴⁾		216,787	D	$81.305⁽⁹⁾	515,657	I	See footnotes⁽¹⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/29/2026		S⁽¹⁴⁾		5,158	D	$81.305⁽⁹⁾	12,269	I	See footnotes⁽²⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/29/2026		S⁽¹⁴⁾		177,768	D	$81.305⁽⁹⁾	422,845	I	See footnotes⁽³⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/29/2026		S⁽¹⁴⁾		34,387	D	$81.305⁽⁹⁾	81,796	I	See footnotes⁽⁴⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/29/2026		S⁽¹⁴⁾		72,672	D	$82.0479⁽¹⁰⁾	442,985	I	See footnotes⁽¹⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/29/2026		S⁽¹⁴⁾		1,729	D	$82.0479⁽¹⁰⁾	10,540	I	See footnotes⁽²⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/29/2026		S⁽¹⁴⁾		59,592	D	$82.0479⁽¹⁰⁾	363,253	I	See footnotes⁽³⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/29/2026		S⁽¹⁴⁾		11,528	D	$82.0479⁽¹⁰⁾	70,268	I	See footnotes⁽⁴⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/29/2026		S⁽¹⁴⁾		162,965	D	$83.1765⁽¹¹⁾	280,020	I	See footnotes⁽¹⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/29/2026		S⁽¹⁴⁾		3,877	D	$83.1765⁽¹¹⁾	6,663	I	See footnotes⁽²⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/29/2026		S⁽¹⁴⁾		133,633	D	$83.1765⁽¹¹⁾	229,620	I	See footnotes⁽³⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/29/2026		S⁽¹⁴⁾		25,850	D	$83.1765⁽¹¹⁾	44,418	I	See footnotes⁽⁴⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/29/2026		S⁽¹⁴⁾		279,671	D	$84.0207⁽¹²⁾	349	I	See footnotes⁽¹⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/29/2026		S⁽¹⁴⁾		6,654	D	$84.0207⁽¹²⁾	9	I	See footnotes⁽²⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/29/2026		S⁽¹⁴⁾		229,334	D	$84.0207⁽¹²⁾	286	I	See footnotes⁽³⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/29/2026		S⁽¹⁴⁾		44,363	D	$84.0207⁽¹²⁾	55	I	See footnotes⁽⁴⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/29/2026		S⁽¹⁴⁾		349	D	$84.59⁽¹³⁾	0	I	See footnotes⁽¹⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/29/2026		S⁽¹⁴⁾		9	D	$84.59⁽¹³⁾	0	I	See footnotes⁽²⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/29/2026		S⁽¹⁴⁾		286	D	$84.59⁽¹³⁾	0	I	See footnotes⁽³⁾⁽⁶⁾⁽⁷⁾
Class A Common Stock	06/29/2026		S⁽¹⁴⁾		55	D	$84.59⁽¹³⁾	0	I	See footnotes⁽⁴⁾⁽⁶⁾⁽⁷⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Class B Common Stock	⁽⁸⁾	06/25/2026		C			732,444	⁽⁸⁾	⁽⁸⁾	Class A Common Stock	732,444	⁽⁵⁾	3,217,008	I	See footnotes⁽¹⁾⁽⁶⁾⁽⁷⁾
Class B Common Stock	⁽⁸⁾	06/25/2026		C			17,427	⁽⁸⁾	⁽⁸⁾	Class A Common Stock	17,427	⁽⁵⁾	76,545	I	See footnotes⁽²⁾⁽⁶⁾⁽⁷⁾
Class B Common Stock	⁽⁸⁾	06/25/2026		C			600,613	⁽⁸⁾	⁽⁸⁾	Class A Common Stock	600,613	⁽⁵⁾	2,637,985	I	See footnotes⁽³⁾⁽⁶⁾⁽⁷⁾
Class B Common Stock	⁽⁸⁾	06/25/2026		C			116,183	⁽⁸⁾	⁽⁸⁾	Class A Common Stock	116,183	⁽⁵⁾	510,292	I	See footnotes⁽⁴⁾⁽⁶⁾⁽⁷⁾

1. Name and Address of Reporting Person^*

Insight Holdings Group, LLC

(Last)

(First)

(Middle)

C/O INSIGHT PARTNERS

1114 AVENUE OF THE AMERICAS, 36TH FLOOR

(Street)

NEW YORK

10036

(City)

(State)

(Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer

Director	X	10% Owner
Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Insight Venture Associates X, L.P.

(Last)

(First)

(Middle)

C/O INSIGHT PARTNERS

1114 AVENUE OF THE AMERICAS, 36TH FLOOR

(Street)

NEW YORK

10036

(City)

(State)

(Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer

Director	X	10% Owner
Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Insight Venture Associates X, Ltd.

(Last)

(First)

(Middle)

C/O INSIGHT PARTNERS

1114 AVENUE OF THE AMERICAS, 36TH FLOOR

(Street)

NEW YORK

10036

(City)

(State)

(Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer

Director	X	10% Owner
Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Insight Venture Partners X, L.P.

(Last)

(First)

(Middle)

C/O INSIGHT PARTNERS

1114 AVENUE OF THE AMERICAS, 36TH FLOOR

(Street)

NEW YORK

10036

(City)

(State)

(Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer

Director	X	10% Owner
Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Insight Venture Partners (Cayman) X, L.P.

(Last)

(First)

(Middle)

C/O INSIGHT PARTNERS

1114 AVENUE OF THE AMERICAS, 36TH FLOOR

(Street)

NEW YORK

10036

(City)

(State)

(Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer

Director	X	10% Owner
Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Insight Venture Partners (Delaware) X, L.P.

(Last)

(First)

(Middle)

C/O INSIGHT PARTNERS

1114 AVENUE OF THE AMERICAS, 36TH FLOOR

(Street)

NEW YORK

10036

(City)

(State)

(Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer

Director	X	10% Owner
Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Insight Venture Partners X (Co-Investors), L.P.

(Last)

(First)

(Middle)

C/O INSIGHT PARTNERS

1114 AVENUE OF THE AMERICAS, 36TH FLOOR

(Street)

NEW YORK

10036

(City)

(State)

(Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer

Director	X	10% Owner
Officer (give title below)		Other (specify below)

Explanation of Responses:

1. See Exhibit 99.1

2. See Exhibit 99.1

3. See Exhibit 99.1

4. See Exhibit 99.1

5. See Exhibit 99.1

6. See Exhibit 99.1

7. See Exhibit 99.1

8. See Exhibit 99.1

9. See Exhibit 99.1

10. See Exhibit 99.1

11. See Exhibit 99.1

12. See Exhibit 99.1

13. See Exhibit 99.1

14. See Exhibit 99.1

Remarks:

This Form 4 is the second of two Form 4s filed relating to the same event. The Form 4 has been split into two filings because there are more than 30 rows in Table I, and the SEC's EDGAR filing system limits a single Form 4 to a maximum of 30 rows in Table I. Each Form 4 is filed by Designated Filer, Insight Holdings Group, LLC.

	Insight Venture Partners X, L.P., By: Insight Venture Associates X, L.P., its general partner, By: Insight Venture Associates X, Ltd., its general partner, By: /s/ Andrew Prodromos/Authorized Officer	06/29/2026
	Insight Venture Partners (Cayman) X, L.P., By: Insight Venture Associates X, L.P., its general partner, By: Insight Venture Associates X, Ltd., its general partner, By: /s/ Andrew Prodromos/Authorized Officer	06/29/2026
	Insight Venture Partners (Delaware) X, L.P., By: Insight Venture Associates X, L.P., its general partner, By: Insight Venture Associates X, Ltd., its general partner, By: /s/ Andrew Prodromos/Authorized Officer	06/29/2026
	Insight Venture Partners X (Co-Investors), L.P., By: Insight Venture Associates X, L.P., its general partner, By: Insight Venture Associates X, Ltd., its general partner, By: /s/ Andrew Prodromos/Authorized Officer	06/29/2026
	Insight Holdings Group, LLC, By: /s/ Andrew Prodromos/Attorney-in-Fact	06/29/2026
	Insight Venture Associates X Ltd., By: /s/ Andrew Prodromos/Authorized Officer	06/29/2026
	Insight Venture Associates X, L.P., By: Insight Venture Associates X, Ltd., its general partner, By: /s/ Andrew Prodromos/Authorized Officer	06/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

Insight funds (NASDAQ: HNGE) convert 1.47M Class B into Class A, then sell

Rhea-AI Filing Summary

Positive

Negative

Insights

Insider Trade Summary 10b5-1

Key Figures

Key Terms

FAQ

What did Insight-affiliated funds do in this Hinge Health (HNGE) Form 4 filing?

How many Hinge Health (HNGE) shares were sold by the Insight entities and at what prices?

What type of securities did the Insight entities convert in Hinge Health (HNGE)?

Are the Insight entities considered insiders or major shareholders of Hinge Health (HNGE)?

Did the Insight entities retain any derivative position after these Hinge Health (HNGE) transactions?

Insight funds (NASDAQ: HNGE) convert 1.47M Class B into Class A, then sell

Rhea-AI Filing Summary

Positive

Negative

Insights

Equity ownership & insider-transactions analyst neutral

Insider Trade Summary 10b5-1

Key Figures

Key Terms

FAQ

What did Insight-affiliated funds do in this Hinge Health (HNGE) Form 4 filing?

How many Hinge Health (HNGE) shares were sold by the Insight entities and at what prices?

What type of securities did the Insight entities convert in Hinge Health (HNGE)?

Are the Insight entities considered insiders or major shareholders of Hinge Health (HNGE)?

Did the Insight entities retain any derivative position after these Hinge Health (HNGE) transactions?